Advertisement
Correspondence| Volume 71, ISSUE 8, e35-e37, April 15, 2012

Effective Deep Brain Stimulation in Heroin Addiction: A Case Report with Complementary Intracranial Electroencephalogram

      Deep brain stimulation (DBS) treatment consists of permanently implanted electrodes that deliver electrical pulses to a target brain region. DBS of the nucleus accumbens shows encouraging results as treatment for certain therapy-resistant psychiatric disorders (
      • Goodman W.K.
      • Alterman R.L.
      Deep brain stimulation for intractable psychiatric disorders.
      ,
      • Denys D.
      • Mantione M.
      • Figee M.
      • van den Munckhof P.
      • Koerselman F.
      • Westenberg H.
      • et al.
      Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder.
      ) and has been suggested for therapy-resistant addiction (
      • Luigjes J.
      • van den Brink W.
      • Feenstra M.
      • van den Munckhof P.
      • Schuurman P.R.
      • Schippers R.
      • et al.
      Deep brain stimulation in addiction: A review of potential brain targets.
      ). Heroin addiction is a chronic relapsing brain disorder seriously affecting both the individual and the public (
      • Hser Y.I.
      • Hoffman V.
      • Grella C.E.
      • Anglin M.D.
      A 33-year follow-up of narcotics addicts.
      ), and DBS could provide a new intervention for those patients who do not respond to current treatments. One central issue in DBS treatment is adaptation of the stimulation parameters: to achieve effective DBS treatment, an extensive optimization period is required in which stimulation parameters— such as contact points, current, and pulse width—are adapted based on clinical observations.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Goodman W.K.
        • Alterman R.L.
        Deep brain stimulation for intractable psychiatric disorders.
        Annu Rev Med. 2011; ([published online ahead of print January 26])
        • Denys D.
        • Mantione M.
        • Figee M.
        • van den Munckhof P.
        • Koerselman F.
        • Westenberg H.
        • et al.
        Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder.
        Arch Gen Psychiatry. 2010; 67: 1061-1068
        • Luigjes J.
        • van den Brink W.
        • Feenstra M.
        • van den Munckhof P.
        • Schuurman P.R.
        • Schippers R.
        • et al.
        Deep brain stimulation in addiction: A review of potential brain targets.
        Mol Psychiatry. 2011; ([published online ahead of print September 20])
        • Hser Y.I.
        • Hoffman V.
        • Grella C.E.
        • Anglin M.D.
        A 33-year follow-up of narcotics addicts.
        Arch Gen Psychiatry. 2001; 58: 503-508
        • Franken I.H.A.
        • Hendriks V.M.
        • van den Brink W.
        Initial validation of two opiate craving questionnaires: The Obsessive Compulsive Drug Use Scale and the Desires for Drug Questionnaire.
        Addict Behav. 2002; 27: 675-685
        • Mazaheri A.
        • Coffey-Corina S.
        • Mangun G.R.
        • Bekker E.M.
        • Berry A.S.
        • Corbett B.A.
        Functional disconnection of frontal cortex and visual cortex in attention-deficit/hyperactivity disorder.
        Biol Psychiatry. 2010; 67: 617-623
        • Zhou H.
        • Xu J.
        • Jiang J.
        Deep brain stimulation of nucleus accumbens on heroin-seeking behaviors: A case report.
        Biol Psychiatry. 2011; 69: e41-e42